Molecular Signature of High Yield (Growth) Influenza A Virus Reassortants Prepared as Candidate Vaccine Seeds

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Ramanunninair, Manojkumar ^a   Le, Jianhua ^a   Onodera, Shiroh ^a   Fulvini, Andrew A ^a   Pokorny, Barbara A ^a   Silverman, Jeanmarie ^a   Devis, Rene ^a   Arroyo, Jennifer M ^a   He, Yu ^a   Boyne, Alex ^b   Bera, Jayati ^b   Halpin, Rebecca ^b   Hine, Erin ^b   Spiro, David J ^c   Bucher, Doris ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b J CRAIG VENTER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC REASSORTMENT; HA GENE; HIGH THROUGHPUT SEQUENCING; HYR GENE; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; M GENE; NA GENE; NONHUMAN; NS GENE; NUCLEOTIDE SEQUENCE; PB1 GENE; PHENOTYPE; PR8 GENE; VIROGENESIS; VIRUS GENOME; WILD TYPE;

GENOME, VIRAL; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MUTATION; NEURAMINIDASE;

HUMAN INFLUENZA VIRUS; INFLUENZA A VIRUS; SPONDIAS PURPUREA;

EID: 84878908164     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065955     Document Type: Article

References (101)

1. Lamb RA, Choppin PW, (1979) Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc Natl Acad Sci USA 76: 4908-12.
2. Lazarowitz SG, Compans RW, Chopin PW, (1971) Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes. Virology 46: 830-43.
3. Lamb RA, Krug RM (1996) Orthomyxoviridae: the Viruses and Their Replication. In Knipe DM, Howley PM, editors. Fields Virology, 2nd ed., Lippincott-Raven, New York, 1353-96.
4. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, et al. (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7: 1306-12.
5. Wise HM, Foeglein A, Sun J, Dalton RM, Patel S, et al. (2009) A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 83: 8021-31.
6. Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, et al. (2012) An Overlapping Protein-Coding Region in Influenza A Virus Segment 3 Modulates the Host Response. Science DOI. 10.1126/science.1222213.
7. Holland JJ, Spindler K, Horodyski F, Grabau E, Nichol S, et al. (1982) Rapid evolution of RNA genomes. Science 215: 1577-85.
8. Lambert LC, Fauci AS, (2010) Influenza vaccines for the future. N Engl J Med 363: 2036-44.
9. Gerdil C, (2003) The annual production cycle for influenza vaccine. Vaccine 21: 1776-79.
10. Payne A, (1953) The influenza programme of WHO. Bull WHO 8: 755-74.
11. Cox NJ, Subbarao K, (1999) Influenza. Lancet 354: 1277-82.
12. Nichol KL, Treanor JJ, (2006) Vaccines for seasonal and pandemic influenza. J Infect Dis 194: S111-S118.
13. Francis Jr T, (1945) Development of the 1943 vaccine. Study of the Commission on Influenza. Amer J Hygiene 42: 1-11.
14. Kilbourne ED, (1969) Future influenza vaccines and the use of genetic recombinants. Bull WHO 41: 643-45.
15. Kilbourne ED, Schulman JL, Schild GC, Schloer G, Swanson J, et al. (1971) Correlated studies of a recombinant influenza virus vaccine. I. Derivation and characterization of the virus and vaccine. J Infect Dis 124: 449-62.
16. Neumann G, Noda T, Kawaoka Y, (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-39.
17. Greenbaum BD, Li OT, Poon LL, Levine AJ, Rabadan R, (2012) Viral reassortment as an information exchange between viral segments. Proc Natl Acad Sci USA 109: 3341-46.
18. Stohr K, Bucher D, Colgate T, Wood J, (2012) Influenza virus surveillance, vaccine strain selection, and manufacture. Methods Mol Biol 865: 147-62.
19. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, et al. (1999) Rescue of influenza A virus from recombinant DNA. J Virol 73: 9679-82.
20. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, et al. (1999) Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 96: 9345-50.
21. Nicolson C, Major D, Wood JM, Robertson JS, (2005) Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine virus produced under a quality system. Vaccine 23: 2943-52.
22. Horimoto T, Murakami S, Muramoto Y, Yamada S, Fujii K, et al. (2007) Enhanced growth of seed viruses for H5N1 influenza vaccines. Virology 366: 23-27.
23. O'Neill E, Donis RO, (2009) Generation and characterization of candidate vaccine viruses for prepandemic influenza vaccines. Curr Top Microbiol Immunol 333: 83-108.
24. Chen GL, Subbarao K, (2009) Live attenuated vaccines for pandemic influenza. Curr Top Microbiol Immunol 333: 109-132.
25. Robertson JS, Bootman JS, Newman R, Oxford JS, Daniels RS, et al. (1987) Structural changes in the hemagglutinin which accompanies embryonated chicken egg adaptation of an influenza A (H1N1) virus. Virology 160: 31-37.
26. Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, et al. (2000) Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol 74: 8502-12.
27. Kumari K, Gulati S, Smith DF, Gulati U, Cummings RD, et al. (2007) Receptor binding specificity of recent human H3N2 influenza viruses. Virol J 4: 42-52.
28. Chen Z, Wang W, Zhou H, Suguitan Jr AL, Shambaugh C, et al. (2010) Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J Virol 84: 44-51.
29. Stevens J, Chen LM, Carney PJ, Garten R, Foust A, et al. (2010) Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs. J Virol 84: 8287-99.
30. Oxford JS, McGeoch DJ, Schild GC, Beare AS, (1978) Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence. Nature 273: 778-779.
31. Baez M, Palese P, Kilbourne ED, (1980) Gene composition of high-yielding influenza vaccine strains obtained by recombination. J Infect Dis 141: 362-365.
32. Klimov AI, Sokolov NI, Orlova NG, Ginzburg VP, (1991) Correlation of amino acid residues in the M1 and M2 proteins of influenza virus with high yielding properties. Virus Res 19: 105-114.
33. Yasuda J, Bucher DJ, Ishihama A, (1994) Growth control of influenza A virus by M1 protein: analysis of transfectant viruses carrying the chimeric M gene. J Virol 68: 8141-46.
34. Offringa DP, Tyson-Medlock V, Ye Z, Levandowski RA, (2000) A comprehensive systematic approach to identification of influenza A virus genotype using RT-PCR and RFLP. J Virol Methods 88: 15-24.
35. Liu T, Muller J, Ye Z, (2002) Association of influenza virus matrix protein with ribonucleoproteins may control viral growth and morphology. Virology 304: 89-96.
36. Fulvini AA, Ramanunninair M, Le J, Pokorny BA, Arroyo JM, et al. (2011) Gene Constellation of Influenza A Virus Reassortants with High Growth Phenotype Prepared as Seed Candidates for Vaccine Production. PLoS ONE 6: e20823.
37. Bergeron C, Valette M, Lina B, Ottmann M, (2010) Genetic content of Influenza H3N2 vaccine seeds. PLoS Curr 5: RRN1165.
38. Varich NL, Gitelman AK, Shilov AA, Smirnov YA, Kaverin NV, (2008) Deviation from the random distribution pattern of influenza A virus gene segments in reassortants produced under non-selective conditions. Arch Virol 153: 1149-54.
39. Schickli JH, Flandorfer A, Nakaya T, Martinez-Sobrido L, Garcia-Sastre A, et al. (2001) Plasmid-only rescue of influenza A virus vaccine candidates. Philos Trans R Soc Lond B Biol Sci 356: 1965-73.
40. Wilson IA, Skehel JJ, Wiley DC, (1981) Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289: 366-373.
41. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG, (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876-82.
42. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
43. Kilbourne ED, Gerhard W, Whitaker CW, (1983) Monoclonal antibodies to the hemagglutinin Sa antigenic site of A/PR/8/34 influenza virus distinguish biologic mutants of swine influenza virus. Proc Natl Acad Sci USA 80: 6399-02.
44. Kilbourne ED, Taylor AH, Whitaker CW, Sahai R, Caton AJ, (1988) Hemagglutinin polymorphism as the basis for low- and high-yield phenotypes of swine influenza virus. Proc Natl Acad Sci USA 85: 7782-85.
45. Widjaja L, Ilyushina N, Webster RG, Webby RJ, (2006) Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs. Virology 350: 137-145.
46. Gorman OT, Bean WJ, Kawaoka Y, Donatelli I, Guo Y, et al. (1991) Evolution of influenza A virus nucleoprotein genes: implications for the origins of H1N1 human and classical swine viruses. J Virol 65: 3704-14.
47. Subbarao K, London W, Murphy BR, (1993) A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol 67: 1761-64.
48. Baigent SJ, McCauley JW, (2003) Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission. Bioassays 25: 657-671.
49. Wang TT, Palese P, (2009) Unraveling the mystery of swine influenza virus. Cell 137: 983-985.
50. Hatta M, Gao P, Halfmann P, Kawaoka Y, (2001) Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293: 1840-42.
51. Iwai A, Shiozaki T, Kawai T, Akira S, Kawaoka Y, et al. (2010) Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem 285: 32064-74.
52. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, et al. (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139: 1255-67.
53. Wanitchang A, Kramyu J, Jongkaewwattana A, (2010) Enhancement of reverse genetics-derived swine-origin H1N1 influenza virus seed vaccine growth by inclusion of indigenous polymerase PB1 protein. Virus Res 147: 145-148.
54. Pancucharova H, Russ G, (2006) PB1-F2 gene in influenza A viruses of different hemagglutinin subtypes. Acta Virol 50: 269-272.
55. Zamarin D, Ortigoza MB, Palese P, (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80: 7976-7983.
56. Varga ZT, Palese P, (2011) The influenza A virus protein PB1-F2: Killing two birds with one stone? Virulence 2: 1-5.
57. Hare K, Shiota M, Kido H, Ohtsu Y, Kashiwagi T, et al. (2001) Influenza virus RNA polymerase PA subunit is a novel serine protease with Ser624 at the active site. Genes Cells 6: 87-97.
58. Sanz-Ezquerro JJ, Zurcher T, De la Luna S, Ortin J, Nieto A, (1996) The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis. J Virol 69: 2420-26.
59. Dias A, Bouvier D, Crepin T, McCarthy AA, Hart DJ, et al. (2009) The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 458: 914-918.
60. Marsh GA, Rabadan R, Levine AJ, Palese P, (2008) Highly Conserved Regions of Influenza A Virus Polymerase Gene Segments Are Critical for Efficient Viral RNA Packaging. J Virol 82: 2295-2304.
61. Muramoto Y, Takada A, Fujii K, Noda T, Iwatsuki-Horimoto K, Watanabe S, Horimoto T, Kida H, Kawaoka Y, (2006) Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol 80: 2318-2325.
62. Perez DR, Donis RO, (1995) A 48-amino-acid region of influenza A virus PB1 protein is sufficient for complex formation with PA. J Virol 69: 6932-39.
63. Gonzalez S, Zurcher T, Ortin J, (1996) Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res 22: 4456-63.
64. Guu TSY, Dong L, Wittung-Stafshede P, Tao YJ, (2008) Mapping the domain structure of the influenza A virus polymerase acidic protein (PA) and its interaction with the basic protein 1 (PB1) subunit. Virology 379: 135-142.
65. Tian SF, Buckler-White AJ, London WT, Reck LJ, Chanock RM, (1985) Nucleoprotein and membrane protein genes are associated with restriction of replication of influenza A/Mallard/NY/78 virus and its reassortants in squirrel monkey respiratory tract. J Virol 53: 771-775.
66. Lubeck MD, Schulman JL, Palese P, (1978) Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein. J Virol 28: 710-716.
67. Downie JC, (1984) A genetic and monoclonal analysis of high-yielding reassortants of influenza A virus used for human vaccines. J Biol Stand 12: 101-110.
68. Klimov A, Ghendon Y, Zavadova H, Broucek J, Medvedeva T, (1983) High reproduction capacity of recombinants between H3N2 human influenza and fowl plague viruses is due to the gene coding for M proteins. Acta Virol 27: 434-438.
69. Liu T, Ye Z, (2002) Restriction of viral replication by mutation of the influenza virus matrix protein. J Virol 76: 13055-61.
70. O'Neill RE, Talon J, Palese P, (1998) The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J 17: 288-96.
71. Hale BG, Randall RE, Ortin J, Jackson D, (2008) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89: 2359-76.
72. Garcia-Sastre A, (2001) Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279: 375-84.
73. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, et al. (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252: 324-30.
74. Greenspan D, Palese P, Krystal M, (1988) Two nuclear location signals in the influenza virus NS1 nonstructural protein. J Virol 62: 3020-26.
75. Marion RM, Zurcher T, de la Luna S, Ortin J, (1997) Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo. J Gen Virol 78: 2447-51.
76. Robb CR, Smith M, Vreede FT, Fodor E, (2009) NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome. J Gen Virol 90: 1398-407.
77. Jin H, Zhou H, Liu H, Chan W, Adhikary L, et al. (2005) Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 336: 113-119.
78. Robertson JS, Nicolson C, Harvey R, Johnson R, Major D, et al. (2011) The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine 29: 1836-43.
79. Lu B, Zhou H, Chan W, Kemble G, Jin H, (2006) Single amino acid substitutions in the hemagglutinin of influenza A/Singapore/21/2004 (H3N2) increase virus growth in embryonated chicken eggs. Vaccine 24: 6691-93.
80. Verity EE, Camuglia S, Agius CT, Ong C, Shaw R, et al. (2012) Rapid generation of pandemic influenza virus vaccine candidate strains using synthetic DNA. Influenza and Other Respiratory Viruses 6: 101-119.
81. Colman PM, Varghese JN, Laver WG, (1983) Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303: 41-44.
82. Lamb RA, Choppin PW, (1983) The gene structure and replication of influenza virus. Annu Rev Biochem 52: 467-506.
83. Varghese JN, Laver WG, Colman PM, (1983) Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature 303: 35-40.
84. Mitnaul LJ, Matrosovich MN, Castrucci MR, Tuzikov AB, Bovin NV, et al. (2000) Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol 74: 6015-20.
85. Vodeiko GM, McInnis J, Chizhikov V, Levandowski RA, (2003) Genetic and phenotypic analysis of reassortants of high growth and low growth strains of influenza B virus. Vaccine 21: 3867-74.
86. Markoff L, Lai CJ, (1982) Sequence of the influenza A/Udorn/72 (H3N2) virus neuraminidase gene as determined from cloned full-length DNA. Virology 119: 288-297.
87. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, et al. (2007) A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525-528.
88. Parmley JL, Hurst LD, (2007) How do synonymous mutations affect fitness? Bioassays 29: 515-519.
89. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, et al. (2006) Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314: 1930-33.
90. Jukes TH, (1980) Silent nucleotide substitutions and the molecular evolutionary clock. Science 210: 973-978.
91. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM, (1999) Predicting the evolution of human influenza A. Science. 286: 1921-25.
92. Miyata T, Yasunaga T, (1980) Molecular evolution of mRNA: a method for estimating evolutionary rates of synonymous and amino acid substitutions from homologous nucleotide sequences and its application. J Mol Evol 16: 23-36.
93. Hamano T, Matsuo K, Hibi Y, Victoriano AF, Takahashi N, et al. (2007) A single-nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production. J Virol 81: 1528-33.
94. Novella IS, Zarate S, Metzger D, Ebendick-Corpus BE, (2004) Positive selection of synonymous mutations in vesicular stomatitis virus. J Mol Biol 342: 1415-21.
95. Plyusnin A, Vapalahti O, Lehvaslaiho H, Apekina N, Mikhailova T, et al. (1995) Genetic variation of wild Puumala viruses within the serotype, local rodent populations and individual animal. Virus Res 38: 25-41.
96. Sironen T, Vaheri A, Plyusnin A, (2001) Molecular evolution of Puumala Hantavirus. J Virol 75: 11803-10.
97. Wong EHM, Smith DK, Rabadan R, Peiris M, Poon LL, (2010) Codon usage bias and the evolution of influenza A viruses. BMC Evolutionary Biology 10: 253-66.
98. Kryazhimskiy S, Bazykin GA, Dushoff J, (2008) Natural selection for nucleotide usage at synonymous and non-synonymous sites in the influenza A genes. J Virol 82: 4938-45.
99. Rabadan R, Levine AJ, Robins H, (2006) Comparison of avian and human influenza A viruses reveals a mutational bias on the viral genomes. J Virol 80: 11887-91.
100. Greenbaum BD, Rabadan R, Levine AJ, (2009) Patterns of oligonucleotides sequences in viral and host cell RNA identify mediators of the host innate immune system. PLOS ONE 4: e5969.
101. Ludwig S, Pleschka S, Planz O, Wolff T, (2006) Ringing the alarm bells: signaling and apoptosis in influenza virus infected cells. Cell Microbiol 8: 375-86.